India · Delayed Price · Currency is INR Pharmaids Pharmaceuticals Statistics
Total Valuation
BOM:524572 has a market cap or net worth of INR 1.27 billion. The enterprise value is 1.47 billion.
| Market Cap | 1.27B |
| Enterprise Value | 1.47B |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:524572 has 35.27 million shares outstanding. The number of shares has decreased by -53.92% in one year.
| Current Share Class | 35.27M |
| Shares Outstanding | 35.27M |
| Shares Change (YoY) | -53.92% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 68.23% |
| Owned by Institutions (%) | n/a |
| Float | 6.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.99 |
| PB Ratio | 2.48 |
| P/TBV Ratio | 6.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.59 |
| EV / Sales | 5.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -26.95% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 5.22% |
| Revenue Per Employee | 9.12M |
| Profits Per Employee | -4.95M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -49.59M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.14% in the last 52 weeks. The beta is -0.10, so BOM:524572's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | -47.14% |
| 50-Day Moving Average | 41.80 |
| 200-Day Moving Average | 52.88 |
| Relative Strength Index (RSI) | 45.86 |
| Average Volume (20 Days) | 17,666 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:524572 had revenue of INR 255.33 million and -138.47 million in losses. Loss per share was -3.91.
| Revenue | 255.33M |
| Gross Profit | 95.47M |
| Operating Income | -191.88M |
| Pretax Income | -202.49M |
| Net Income | -138.47M |
| EBITDA | -164.46M |
| EBIT | -191.88M |
| Loss Per Share | -3.91 |
Balance Sheet
The company has 2.39 million in cash and 201.32 million in debt, with a net cash position of -198.93 million or -5.64 per share.
| Cash & Cash Equivalents | 2.39M |
| Total Debt | 201.32M |
| Net Cash | -198.93M |
| Net Cash Per Share | -5.64 |
| Equity (Book Value) | 513.11M |
| Book Value Per Share | 14.65 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 37.39%, with operating and profit margins of -75.15% and -54.23%.
| Gross Margin | 37.39% |
| Operating Margin | -75.15% |
| Pretax Margin | -79.30% |
| Profit Margin | -54.23% |
| EBITDA Margin | -64.41% |
| EBIT Margin | -75.15% |
| FCF Margin | n/a |
Dividends & Yields
BOM:524572 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 53.92% |
| Shareholder Yield | 53.92% |
| Earnings Yield | -10.87% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |